Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.260
-0.030 (-1.31%)
At close: Mar 13, 2026, 4:00 PM EDT
2.260
0.00 (0.00%)
After-hours: Mar 13, 2026, 7:26 PM EDT
Nkarta Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
105
Market Cap
160.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tonix Pharmaceuticals Holding | 10.30M |
| Rani Therapeutics Holdings | 1.20M |
| Molecular Partners AG | 856.30K |
| Connect Biopharma Holdings | 762.00K |
| Artiva Biotherapeutics | 251.00K |
| Adagene | 103.20K |
NKTX News
- 14 days ago - Nkarta to Participate in March Investor Conferences - GlobeNewsWire
- 3 months ago - Nkarta to Participate in Evercore Healthcare Conference - GlobeNewsWire
- 3 months ago - Nkarta: Pushing Deeper And Deeper Into A Discount Vs. Their Holdings, For No Real Reason - Seeking Alpha
- 4 months ago - Nkarta Reports Third Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 4 months ago - Nkarta to Participate in November Investor Conferences - GlobeNewsWire
- 5 months ago - Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting - GlobeNewsWire
- 6 months ago - Nkarta to Participate in a September Investor Conference - GlobeNewsWire
- 7 months ago - Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire